Premium Nahrungsergänzungsmittel | artgerecht

Immunoglobulin Subclass – Definition and Clinical Role

Immunoglobulin subclasses are subdivisions of antibody classes in the human immune system, such as IgG1 to IgG4. They differ in structure and immune function.

Regular tips about health Regular tips about health

Things worth knowing about "Immunoglobulin Subclass"

Immunoglobulin subclasses are subdivisions of antibody classes in the human immune system, such as IgG1 to IgG4. They differ in structure and immune function.

What Are Immunoglobulin Subclasses?

Immunoglobulin subclasses are further divisions within the five main classes of antibodies: IgG, IgA, IgM, IgD, and IgE. The IgG class is divided into four subclasses (IgG1, IgG2, IgG3, and IgG4), while IgA has two subclasses (IgA1 and IgA2). These subclasses differ in their molecular structure, their concentration in the blood, and their specific roles in the immune response.

Biological Functions

Each immunoglobulin subclass performs distinct functions in immune defense:

IgG1 and IgG3: Primary antibodies against protein antigens such as viruses and bacteria. IgG3 is particularly efficient at activating the complement system.
IgG2: Plays a key role in the defense against polysaccharide antigens found on the surface of certain bacteria, such as Streptococcus pneumoniae and Haemophilus influenzae.
IgG4: Involved in chronic immune responses and allergic processes; plays a role in immune tolerance mechanisms.
IgA1 and IgA2: IgA1 predominates in blood serum, while IgA2 is more abundant in mucosal secretions (e.g., intestinal tract, respiratory tract) and is more resistant to bacterial proteases.

Clinical Relevance

Immunoglobulin subclasses are clinically significant because a deficiency in one or more subclasses can lead to increased susceptibility to infections even when total immunoglobulin levels appear normal. The most commonly affected subclasses are IgG2 and IgG3. An IgG subclass deficiency is one of the most common primary immunodeficiencies and may present as recurrent respiratory tract infections, sinusitis, or otitis media.

Conditions Associated with Subclass Abnormalities

IgG subclass deficiency: Increased vulnerability to bacterial infections, especially those caused by encapsulated pathogens.
IgG4-related disease (IgG4-RD): A rare inflammatory condition characterized by elevated IgG4 levels and fibro-inflammatory changes across multiple organs.
Selective IgA deficiency: The most common primary immunodeficiency; affects both IgA1 and IgA2, increasing the risk of respiratory and gastrointestinal infections as well as autoimmune disorders.
Common variable immunodeficiency (CVID): Often involves deficiencies across multiple subclasses.

Diagnosis

Immunoglobulin subclass levels are measured from a blood sample using nephelometry or ELISA (enzyme-linked immunosorbent assay). Typically, all four IgG subclasses as well as IgA1 and IgA2 are analyzed. Results are compared against age-specific reference ranges, as subclass concentrations vary considerably during childhood. Subclass testing is most informative when interpreted alongside clinical symptoms and additional immunological evaluations.

Treatment of Subclass Deficiency

The management of an immunoglobulin subclass deficiency depends on the severity of clinical symptoms:

Monitoring and infection prevention: Appropriate for mild cases without frequent or severe infections.
Long-term antibiotic prophylaxis: Used to reduce the frequency of recurrent infections.
Immunoglobulin replacement therapy (IVIG/SCIG): Intravenous or subcutaneous administration of immunoglobulins in patients with severe clinical manifestations. This therapy replaces missing antibodies and significantly reduces infection rates.
Vaccination: Targeted immunization against encapsulated bacteria (e.g., pneumococcal, meningococcal, and Haemophilus influenzae type b vaccines) is an important preventive measure.

References

Bonilla FA, Barlan I, Chapel H et al. - International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38-59.
Schroeder HW Jr, Cavacini L - Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41-52.
World Health Organization (WHO) - Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol. 1999;118 Suppl 1:1-28.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.